Discovery

Quanta Presents Preclinical Data for QTX3544, a Potent and Selective G12V-preferring Multi-KRAS Inhibitor, in Late-Breaking Session at Annual AACR Meeting 2024

Retrieved on: 
Monday, April 8, 2024
Discovery, MAPK, Patient, Lung, Doctor of Philosophy, MD, IND, AACR, Therapy, Stomach

RADNOR, Pa. & SOUTH SAN FRANCISCO, Calif., April 08, 2024 (GLOBE NEWSWIRE) -- Quanta Therapeutics, a privately-held biopharmaceutical company leading innovative development of direct, oral therapeutics for RAS-driven cancers, announced the presentation of QTX3544, a multi-KRAS inhibitor with G12V-preferring activity (G12V+ multi-KRAS), in a late-breaking poster presentation session at the American Association of Cancer Research (AACR) Annual Meeting.

Key Points: 
  • QTX3544 demonstrated a favorable preclinical profile, including high selectivity and potent activity against multiple KRAS mutations with preference for the G12V mutation.
  • Additionally, QTX3544 significantly inhibited KRASG12V tumor growth in preclinical animal models and exhibited promising oral bioavailability and pharmacokinetic properties.
  • “We continue to advance our pipeline of candidates against KRAS-driven cancer mutations focusing on the most prevalent drivers, G12D and G12V,” said Perry Nisen, MD, PhD, Chief Executive Officer of Quanta.
  • We look forward to completing IND-enabling studies for QTX3544 this year to support future clinical studies in patients with G12V-mutated solid tumors, a population without targeted treatment options.”
    Data from the presentation are summarized below.

Coherent Loans James Webb Space Telescope Demonstration Mirror to Space Foundation Discovery Center

Retrieved on: 
Monday, April 8, 2024
Discovery, Beryllium, Science, MDT, COHR, Education, Gold, History, Coherence, Senior, STEAM, Mathematics, JWST, Coherent Corp., OLED, Hubble Space Telescope, Engineering

PITTSBURGH, April 08, 2024 (GLOBE NEWSWIRE) -- Coherent Corp. (NYSE: COHR), a leader in advanced optical systems, announced today an agreement with the Space Foundation Discovery Center , located in Colorado Springs, Colorado, to provide on loan a demonstration mirror developed for the James Webb Space Telescope (JWST).

Key Points: 
  • PITTSBURGH, April 08, 2024 (GLOBE NEWSWIRE) -- Coherent Corp. (NYSE: COHR), a leader in advanced optical systems, announced today an agreement with the Space Foundation Discovery Center , located in Colorado Springs, Colorado, to provide on loan a demonstration mirror developed for the James Webb Space Telescope (JWST).
  • The Space Foundation Discovery Center focuses on inspiring and educating individuals of all ages about space, science, and technology.
  • “The hexagonal mirrors are not only a testament to the technological expertise behind the James Webb Space Telescope, but also a symbol of the collaborative spirit driving humanity's exploration of the universe,” said Rachel English , Space Foundation Discovery Center senior curator.
  • Attendees are invited to join Coherent and the Discovery Center representatives for this ceremony, which will take place at 4:00 p.m. MDT.

Addex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Modulator Therapeutics for Neurological Disorders

Retrieved on: 
Wednesday, April 3, 2024
Discovery, Epilepsy, GABAB, Senior, Glutamic acid, Dyskinesia, Glutamate (neurotransmitter), Drug discovery, Partnership, TBI, SIX, Chronic cough, NAM, CHF5, Therapy, DSM-IV codes, Janssen, Safety, ADX71149, Allosteric regulation, Janssen Pharmaceuticals, Dipraglurant, Research fellow, PAM, Pharmaceutical industry

With initial funding of $63 million from Perceptive Xontogeny Venture Fund II, with participation from Perceptive Life Sciences Fund and Acorn Bioventures, Neurosterix will acquire a portfolio of preclinical assets and the allosteric modulator drug discovery technology platform from Addex and accelerate their development.

Key Points: 
  • With initial funding of $63 million from Perceptive Xontogeny Venture Fund II, with participation from Perceptive Life Sciences Fund and Acorn Bioventures, Neurosterix will acquire a portfolio of preclinical assets and the allosteric modulator drug discovery technology platform from Addex and accelerate their development.
  • In return, Addex will receive CHF5 million and a 20% equity interest in Neurosterix.
  • “The launch of Neurosterix in partnership with Perceptive is an important validation of the Addex allosteric modulator drug discovery technology platform and provides the resources to accelerate development of important preclinical assets, including the M4 PAM and mGlu7 negative allosteric modulator (NAM) programs, into the clinic,” said Tim Dyer, CEO of Addex.
  • To guide the launch of Neurosterix, Tim Dyer, in addition to his role at Addex, will assume the role of CEO of Neurosterix.

Demand for Bitsight Exposure Management Products Soars by 2x as Cyber Threats Intensify and Regulations Drive Increased Scrutiny

Retrieved on: 
Tuesday, April 9, 2024
Discovery, BearingPoint, KEV, Organization, Risk management, Growth, Risk, CISO, Security, Critical

BOSTON, April 9, 2024 /PRNewswire/ -- Bitsight today announced customer growth of more than 215% for its Enhanced External Attack Surface Management (EASM) and the launch of more than 20 new features for exposure management over the past year. Coupled with the  robust expansion of its Third-Party Risk Management solutions as regulations in Europe intensify, and a growing desire from security leaders to consume contextualized threat insights from Bitsight's Data Solutions feed, the achievements mark key milestones in the company's cyber risk management strategy.

Key Points: 
  • Bitsight External Attack Surface Management and Data Solutions help security and risk leaders identify, prioritize, communicate, and mitigate risk across their digital ecosystem.
  • Over the past 12 months, Bitsight has increased investment in its industry-leading data offerings,  which provide high-value insight into cyber security risks.
  • The expanded coverage and new delivery methods help Bitsight customers more rapidly identify areas of impact and mitigate issues faster.
  • Learn more about Bitsight's exposure management solutions or read the latest KuppingerCole Leadership Compass Report, which names Bitsight as an overall leader, product leader, innovation leader and market leader, here .

Asians in Advertising Breaking Barriers Summit

Retrieved on: 
Tuesday, April 9, 2024
Discovery, Publicis, Partnership, Bias, Carat, Syndrome, Mark Huffam, Senior, Warner Bros., AANHPI, Multimedia, Marketing, Movement, Management

LOS ANGELES, April 9, 2024 /PRNewswire/ -- Asians in Advertising proudly announces the return of its highly anticipated annual Breaking Barriers Summit, scheduled for Friday, May 3, 2024.

Key Points: 
  • LOS ANGELES, April 9, 2024 /PRNewswire/ -- Asians in Advertising proudly announces the return of its highly anticipated annual Breaking Barriers Summit, scheduled for Friday, May 3, 2024.
  • The Breaking Barriers Summit is designed to empower attendees to advance their careers by addressing the unique challenges Asian Americans face in advertising, marketing, and communications.
  • "We're deeply honored to present our third annual Breaking Barriers Summit," expressed Bernice Chao, co-founder of Asians in Advertising.
  • Discovery
    Asians in Advertising aims to develop a community, create opportunities, and elevate Asians to higher leadership positions in the advertising industry.

ATHA Energy Provides Update on 2024 Exploration Program

Retrieved on: 
Wednesday, March 20, 2024
Diamond, Uranium, FRA, Kivalliq Region, Artemis program, National Instrument 43-101, Athabasca Basin, UPDATE, ANT, VLF, Mag, ASX, News, Acquisition, National instrument, Scheme, Discovery, EM, Probability, GMZ, Athabasca, Uranium mining

VANCOUVER, British Columbia, March 20, 2024 (GLOBE NEWSWIRE) -- ATHA Energy Corp. (TSX.V: SASK) (FRA: X5U) (OTCQB: SASKF) (“ATHA” or the “Company”), holder of the largest uranium exploration portfolio in two of the highest-grade uranium districts in the world, is pleased to announce plans for its 2024 Exploration Program. At the 100%-owned Angilak Project in Nunavut, the Company will focus on diamond drilling with the objective of deposit expansion and discovery. In the Athabasca Basin, the Company will be further advancing nine of its 100%-owned projects through a combination of ground and airborne geophysical surveys. The objective of the Athabasca Basin Program is to continue to mature ATHA’s geological understanding within each of its projects, increasing the probability of discovery and optimise capital expenditure during future drill campaigns. Additionally, subject to the completion of the Company’s proposed scheme of arrangement (the “Scheme”) with 92 Energy Limited (ASX: 92E) ("92E”), development of 92 Energy’s projects, such as Gemini, which hosts the recently discovered high-grade GMZ showing, will be incorporated into the into the Company’s Athabasca Basin Exploration Program. The Company will provide an update inclusive of drilling plans for the Gemini project, post closing of the Scheme.

Key Points: 
  • The objective of the 2024 Athabasca Basin Exploration Program is to advance ATHA’s exploration model, generating additional high-priority targets for future drill programs.
  • The Athabasca Basin Exploration Program is currently underway and is projected to continue through the end of Q3 2024.
  • VANCOUVER, British Columbia, March 20, 2024 (GLOBE NEWSWIRE) -- ATHA Energy Corp. (TSX.V: SASK) (FRA: X5U) (OTCQB: SASKF) (“ATHA” or the “Company”), holder of the largest uranium exploration portfolio in two of the highest-grade uranium districts in the world, is pleased to announce plans for its 2024 Exploration Program.
  • The 2024 Athabasca Basin Exploration Program is already underway and is slated to continue through to the end of Q3 2024.

Howard Hughes Announces Partnership With Discovery Land Company at Ward Village® to Develop New Premier Residential Tower Designed by Robert A.M. Stern Architects

Retrieved on: 
Tuesday, March 19, 2024
Diamond, Discovery, Discovery Land Company, Partnership, Howard Hughes, IBM, VITA, HHH, Heart, IBM Building, Collection, Hotel

‘Ilima is designed to deliver an unrivaled island living experience with a refined aesthetic, expansive amenities, and sweeping ocean and Diamond Head views.

Key Points: 
  • ‘Ilima is designed to deliver an unrivaled island living experience with a refined aesthetic, expansive amenities, and sweeping ocean and Diamond Head views.
  • ‘Ilima, along with its companion tower Melia Ward Village, is being designed by celebrated architecture firm Robert A.M. Stern Architects.
  • A 33-story tower comprising 148 residences, ‘Ilima will include Discovery’s signature concierge services and curated amenities providing the distinguished residential experience for which the company is known.
  • The Launiu Ward Village—the community’s recently announced 11th tower—has commenced pre-sales and is demonstrating strong interest that illustrates the continued market demand for Ward Village.

Captain Planet Foundation Raises More Than $800,000 at Annual Gala Honoring Environmental Heroes Josh Bernstein and Oluwaseyi Moejoh

Retrieved on: 
Sunday, March 17, 2024
Cox Media Group, Lindblad, History, Genuine Parts Company, Into, Georgia Aquarium, Gala, NFL, Corporate responsibility, HRH, The Coca-Cola Company, NASA, Eurosport 1, Chef, Climate change, Knowledge, Cat, Superhero, Student, STEM, Discovery, Francis Ford, Environment, Cox Enterprises, School, Social impact, Environmental justice, Atlanta Gas Light, Ray, Day, Unknown, Delta Air Lines

ATLANTA, March 17, 2024 (GLOBE NEWSWIRE) -- Last night, Captain Planet Foundation, the global non-profit, held their annual Gala at Flourish Atlanta and recognized environmental heroes, Josh Bernstein and Oluwaseyi Moejoh. Additionally, Cox Enterprises received the Corporate Superhero for the Earth Award. The benefit raised more than $800,000 to support the Foundation’s worldwide educational programming and grant-making efforts to engage and empower young people to be problem solvers for the planet. The Gala was hosted by Atlanta Journal-Constitution’s The Monica Pearson Show host, Monica Kaufman Pearson.

Key Points: 
  • ATLANTA, March 17, 2024 (GLOBE NEWSWIRE) -- Last night, Captain Planet Foundation , the global non-profit, held their annual Gala at Flourish Atlanta and recognized environmental heroes, Josh Bernstein and Oluwaseyi Moejoh.
  • The Gala was hosted by Atlanta Journal-Constitution’s The Monica Pearson Show host, Monica Kaufman Pearson.
  • More than 400 guests were in attendance to celebrate the honorees and the impact that Captain Planet Foundation has had on youth around the world.
  • Captain Planet Foundation also introduced the Laura Turner Seydel Legacy Fund which will support the Planeteer Alliance, additional scholarships, and programing for the Foundation.

Addex to Present at the Bio-Europe Spring 2024 Conference

Retrieved on: 
Thursday, March 14, 2024
Discovery, Biology, Therapy

Geneva, Switzerland, March 14, 2024 – Addex Therapeutics (SIX: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced today that CEO, Tim Dyer, will present at the Bio-Europe Spring 2024 conference taking place March 18 - 20, 2024 in Barcelona, Spain.

Key Points: 
  • Geneva, Switzerland, March 14, 2024 – Addex Therapeutics (SIX: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced today that CEO, Tim Dyer, will present at the Bio-Europe Spring 2024 conference taking place March 18 - 20, 2024 in Barcelona, Spain.
  • In his presentation, Mr Dyer will provide a corporate update and discuss recent developments at Addex.
  • Mr Dyer and Dr Lütjens will be available for one-on-one meetings throughout the conference.
  • For more information or to schedule a one-on-one meeting, please reach out through the conference online partnering system or contact [email protected] .

Veritone to Showcase Innovative AI Solutions, Including New Ask Veri Tool, at the 2024 NAB Show

Retrieved on: 
Wednesday, April 3, 2024
Technology, Entertainment, Podcast, General Entertainment, Artificial Intelligence, Other Communications, Publishing, Marketing, Software, Advertising, Other Entertainment, Communications, TV and Radio, Data Management, Discovery, Flex, ROI, Las Vegas Convention Center, Organization, Benchmarking, Intelligence, NAB, AI, Creative Artists Agency, AWS, CBS News, Amazon Web Services, API, Future, IABM, Content intelligence, IHeartRadio, NAB Show

Veritone, Inc. (NASDAQ: VERI), a leader in designing human-centered AI solutions, today unveils details of its participation at the 2024 NAB Show in Las Vegas from April 13 to 17.

Key Points: 
  • Veritone, Inc. (NASDAQ: VERI), a leader in designing human-centered AI solutions, today unveils details of its participation at the 2024 NAB Show in Las Vegas from April 13 to 17.
  • “We are thrilled to once again participate in the NAB Show, where we will highlight our latest AI solutions for media and entertainment,” said Sean King, general manager for Veritone Media and Entertainment.
  • At NAB, Veritone will introduce new product features including an enhanced user interface and navigation.
  • Veritone AI Solutions Group – Veritone’s team of AI experts meets customers where they are in their AI journey, helping companies get started or optimize, improve and expand AI implementation.